Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 27;4(1):55.
doi: 10.1038/s44184-025-00169-z.

Repurposing medications to prevent psychosis

Affiliations
Review

Repurposing medications to prevent psychosis

Bruce M Cohen et al. Npj Ment Health Res. .

Abstract

Individuals who experience schizophrenias often had premorbid signs. However, they rarely develop psychosis until adolescence or young adulthood, a period of brain remodeling. Current efforts to reduce risk for psychosis have shown only modest benefit. This paper reviews evidence on mechanisms that may underlie the development of psychosis. Based on that evidence, it identifies existing medications that target these mechanisms and may be repurposed to prevent progression to psychosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Knudsen, C. B. et al. Early childhood neurocognition in relation to middle childhood psychotic experiences in children at familial high risk of schizophrenia or bipolar disorder and population-based controls: the Danish high risk and resilience study. Schizophr. Bull.49, 756–767 (2023). - PMC - PubMed
    1. Jeon, S. M., Lee, D. Y., Cha, S. & Kwon, J. W. Psychiatric comorbidities and schizophrenia in youths with attention-deficit/hyperactivity disorder. JAMA Netw. Open6, e2345793 (2023). - PMC - PubMed
    1. Benrimoh, D. et al. On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis. Mol. Psychiatry29, 1361–1381 (2024). - PubMed
    1. Fett, A. J., Reichenberg, A. & Velthorst, E. Lifespan evolution of neurocognitive impairment in schizophrenia - a narrative review. Schizophr. Res Cogn.28, 100237 (2022). - PMC - PubMed
    1. Insel, T. R. Rethinking schizophrenia. Nature468, 187–193 (2010). - PubMed

LinkOut - more resources